The FDA’s Molecular and Clinical Genetics Panel of the Medical Devices (MCGP) advisory committee convened to vote on 3 questions regarding the Galleri multicancer early detection test. 1 The 3 ...

The FDA has approved lirafugratinib (Lyrfigtu), an investigational oral FGFR2 inhibitor, as a treatment for patients with ...

With prostate cancer survival continuing to improve, the long-term cardiovascular consequences of androgen deprivation ...

Martin T, Usmani S, Berdeja JG, et al. Ciltacabtagene autoleucel in patients with heavily pretreated relapsed/refractory multiple myeloma: 5-year follow-up from CARTITUDE-1. Blood. 2024;144 (suppl ...

Experts preview ASTRO 2026 presentations to watch, including those on SOFT Preop, PSMAgRT, radiosurgery for depression, and AI tools for patient safety.

A prospective, multicenter study found that a blood-based miRNA assay combined with CA19-9 improved early detection of ...

Final 5-year IMCgp100-202 data show tebentafusp improved OS vs investigator’s choice in untreated HLA-A*02:01–positive metastatic uveal melanoma. Tebentafusp-tebn (Kimmtrak) continued to confer an ...

"Patients [with cancer] and physicians would rather have a fixed-duration treatment, if possible," said Julie M. Vose, MD, MBA, at SOHO 2026. Posters highlighted sex-based differences in aggressive ...

Jasmine Zain, MD, described how pre-existing CHIP mutations should inform pre-infusion risk counseling and treatment ...

The FDA cleared the Triton 1 robotic endoscopy system for diagnostic and therapeutic procedures such as colorectal cancer ...

Poster sessions at WCLC 2026 detail how surgery, nursing, and pathology can contribute to the multidisciplinary care of ...

At SOHO 2026, experts highlighted new findings and advances across diseases including lymphoma, myelodysplastic syndrome, and leukemia.